Practicing clinicians know all too well that often life intervenes into meticulously planned career path. Endocrine News shares a few tips on steps you can take if you have to be out of the office for a while. For Sarah Hart-Unger, MD, a pediatric endocrinologist at Joe DiMaggio Children’s Hospital at Memorial Healthcare System in...
CEU Preview: Challenging Cases in Lipid Management with Lisa Tannock, MD
Next month, the Endocrine Society’s Clinical Endocrinology Update will kick off in Miami, during which attendees will hear about the latest breakthroughs in patient care, as well as those cases that may prove difficult for clinicians. One such session is Lisa Tannock’s Meet-the-Professor presentation on Thursday, September 5, titled “Challenging Cases in Lipid Management.” Cardiovascular...Clinical Endocrinology Update Goes Bicoastal for a Second Year
After the success of last year’s special issue to promote and highlight the Endocrine Society’s Clinical Endocrinology Update (CEU) program, we decided to make it an annual tradition. For the second year in a row, CEU will take place twice in the September on both the East and West Coasts — Sept. 5 – 7... The advent of newer — often very expensive — drugs has driven up the cost of care for diabetes. But older, less expensive medications can often still get the job done. Treating diabetes with lower-cost drugs might not only help a patient’s pocketbook, they might benefit the patient’s health as well. That will be one...Insulin Manufacturers Offering Help to Government Employees with Diabetes Affected by the Shutdown
As the government shutdown lingers into its second month, there have been numerous stories in the media about government employees going without their medications, including insulin. To ease some of that burden, three insulin manufacturers — Eli Lilly and Company, Novo Nordisk, and Sanofi — are providing outreach to insulin-dependent patients affected by the partial...
Aside from the chances of becoming addicted or even dying from an overdose, opioids have also proven damaging to the endocrine system. An awareness by both patients and physicians is a much-needed first step to combatting these often severe conditions. Opioids have been grabbing headlines for the past couple of years. They’ve become an epidemic,...
CEU Preview: Controversies Continue to Confound Testosterone Therapy
At CEU, experts will take a case-based approach to exploring the controversies involved in testosterone therapy in the session “Case-based Debate of Whether to Start Testosterone Therapy and How to Monitor.” Despite — or perhaps because of — the huge increase in recent years in men requesting treatment for low testosterone levels, controversies continue to...House Calls: Using “Telediabetes” to Improve Veterans’ Health
The telediabetes program used by the VA Pittsburgh Healthcare System combines electronic consulting with ongoing telephone-based care. The results show that this form of healthcare could improve outcomes in patients with type 2 diabetes, especially in rural areas where endocrinologists are scarce. The number of endocrinologists continues to dwindle while rates of two of the...
